"Chelation Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Therapy of heavy metal poisoning using agents which sequester the metal from organs or tissues and bind it firmly within the ring structure of a new compound which can be eliminated from the body.
Descriptor ID |
D015913
|
MeSH Number(s) |
E02.319.155
|
Concept/Terms |
Chelation Therapy- Chelation Therapy
- Therapy, Chelation
- Chelation Therapies
- Therapies, Chelation
|
Below are MeSH descriptors whose meaning is more general than "Chelation Therapy".
Below are MeSH descriptors whose meaning is more specific than "Chelation Therapy".
This graph shows the total number of publications written about "Chelation Therapy" by people in this website by year, and whether "Chelation Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2005 | 0 | 2 | 2 |
2009 | 1 | 0 | 1 |
2010 | 2 | 0 | 2 |
2011 | 0 | 1 | 1 |
2014 | 1 | 0 | 1 |
2019 | 1 | 0 | 1 |
2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Chelation Therapy" by people in Profiles.
-
Barriers and Facilitators to Chronic Red Cell Transfusion Therapy in Pediatric Sickle Cell Anemia. J Pediatr Hematol Oncol Nurs. 2022 Jul-Aug; 39(4):209-220.
-
Site-specific chelation therapy with EDTA-loaded albumin nanoparticles reverses arterial calcification in a rat model of chronic kidney disease. Sci Rep. 2019 02 22; 9(1):2629.
-
Targeted chelation therapy with EDTA-loaded albumin nanoparticles regresses arterial calcification without causing systemic side effects. J Control Release. 2014 Dec 28; 196:79-86.
-
Reduced transverse relaxation rate (RR2) for improved sensitivity in monitoring myocardial iron in thalassemia. J Magn Reson Imaging. 2011 Jun; 33(6):1510-6.
-
Rapid monitoring of iron-chelating therapy in thalassemia major by a new cardiovascular MR measure: the reduced transverse relaxation rate. NMR Biomed. 2011 Aug; 24(7):771-7.
-
Safety and efficacy of high dose intravenous desferrioxamine for reduction of iron overload in sickle cell disease. Pediatr Blood Cancer. 2010 Dec 15; 55(7):1338-42.
-
Challenges associated with metal chelation therapy in Alzheimer's disease. J Alzheimers Dis. 2009; 17(3):457-68.
-
Discontinuing prophylactic transfusions used to prevent stroke in sickle cell disease. N Engl J Med. 2005 Dec 29; 353(26):2769-78.
-
Methods for noninvasive measurement of tissue iron in Cooley's anemia. Ann N Y Acad Sci. 2005; 1054:358-72.